Sustained rescue of prefrontal circuit dysfunction by antidepressant-induced spine formation

Moda-Sava, R. N., Murdock, M. H., Parekh, P. K., Fetcho, R. N., Huang, B. S., Huynh, T. N., Witztum, J., Shaver, D. C. +11 more·2019·Science

Cited by (644)

Items 201–300 of 644

  1. Sustained antidepressant effects of ketamine metabolite involve GABAergic inhibition-mediated molecular dynamics in aPVT glutamatergic neurons
    Ayako Kawatake-Kuno, Haiyan Li, Hiromichi Inaba, Momoka Hikosaka, Erina Ishimori, Takatoshi Ueki, Yury Garkun, Hirofumi Morishita, Shuh Narumiya, Naoya Oishi et al. · 2024 · Neuron
  2. Tabernanthalog Reduces Motivation for Heroin and Alcohol in a Polydrug Use Model
    Jasper A. Heinsbroek, Giuseppe Giannotti, Joel Bonilla, David E. Olson, Jamie Peters · 2023 · Psychedelic Medicine
  3. The Role of Glutamate Underlying Treatment-resistant Depression
    Jeongseop Kim, Tae-Eun Kim, Seung‐Hwan Lee, Ja Wook Koo · 2023 · Clinical Psychopharmacology and Neuroscience
  4. Ketamine rescues anhedonia by cell-type- and input-specific adaptations in the nucleus accumbens
    Federica Lucantonio, Jacob Roeglin, Shuwen Li, Jaden Lu, Aleesha Shi, Katherine Czerpaniak, Francesca Romana Fiocchi, Leonardo Bontempi, Brenda C. Shields, Carlos A. Zarate et al. · 2025 · Neuron
  5. Comparison of physiological and behavioral responses to chronic restraint stress between C57BL/6J and BALB/c mice
    Shoko Tsuchimine, Hitomi Matsuno, Kazunori O’Hashi, Shuichi Chiba, Aya Yoshimura, Hiroshi Kunugi, Kazuhiro Sohya · 2020 · Biochemical and Biophysical Research Communications
  6. Repurposing Ketamine in Depression and Related Disorders: Can This Enigmatic Drug Achieve Success?
    Ezio Carboni, Anna Rosa Carta, Elena Carboni, Antonello Novelli · 2021 · Frontiers in Neuroscience
  7. Symptomatic and neurotrophic effects of GABAA receptor positive allosteric modulation in a mouse model of chronic stress
    Ashley M. Bernardo, Philip Lee, Michael D Marcotte, Md Yeunus Mian, Sepideh Rezvanian, Dishary Sharmin, Aleksandra Kovačević, Miroslav M. Savić, James Minton Cook, Etienne L. Sibille et al. · 2022 · Neuropsychopharmacology
  8. Chronic corticosterone exposure causes anxiety- and depression-related behaviors with altered gut microbial and brain metabolomic profiles in adult male C57BL/6J mice
    Hirotaka Shoji, Yasuhiro Maeda, Tsuyoshi Miyakawa · 2024 · Molecular Brain
  9. Janus-Faced Fluorescence Imaging Agent for Malondialdehyde and Formaldehyde in Brains
    Xin Wang, Di Su, Chunyu Liu, Ping Li, Ran Zhang, Wen Zhang, Wei Zhang, Bo Tang · 2022 · Analytical Chemistry
  10. Rapid-acting antidepressant drugs modulate affective bias in rats
    Justyna K. Hinchcliffe, Sarah A. Stuart, Christian M. Wood, Julia M. Bartlett, Katie Kamenish, Roberto Arban, Christopher W. Thomas, Aslihan Selimbeyoglu, Shaun Hurley, Bastian Hengerer et al. · 2024 · Science Translational Medicine
  11. Bryostatin 1 Promotes Synaptogenesis and Reduces Dendritic Spine Density in Cortical Cultures through a PKC-Dependent Mechanism
    Calvin Ly, Akira Shimizu, Maxemiliano V. Vargas, Whitney C. Duim, Paul A. Wender, David E. Olson · 2020 · ACS Chemical Neuroscience
  12. Ketamine, but not guanosine, as a prophylactic agent against corticosterone-induced depressive-like behavior: Possible role of long-lasting pro-synaptogenic signaling pathway
    Anderson Camargo, Ana Paula Dalmagro, Márcia María de Souza, Ana Lúcia Bertarello Zeni, Ana Lúcia S. Rodrigues · 2020 · Experimental Neurology
  13. Gray matter volume of rostral anterior cingulate cortex predicts rapid antidepressant response to ketamine
    Ana Lucía Herrera-Meléndez, Anna Stippl, Sabine Aust, Milan Scheidegger, Erich Seifritz, Isabella Heuser, Christian Otte, Malek Bajbouj, Simone Grimm, Matti Gärtner · 2020 · European Neuropsychopharmacology
  14. Sigma-1 receptor activation mediates the sustained antidepressant effect of ketamine in mice via increasing BDNF levels
    Hui Ma, Jinfeng Li, Xin Qiao, Yue Zhang, Xiao-juan Hou, Honglei Chen, Honglei Chen, Yong Zhang, Yunfeng Li · 2023 · Acta Pharmacologica Sinica
  15. Ketamine increases vmPFC activity: Effects of (R)- and (S)-stereoisomers and (2R,6R)-hydroxynorketamine metabolite
    Brendan D. Hare, Santosh Pothula, Ralph Dileone, Ronald S. Duman · 2020 · Neuropharmacology
  16. Psilocybin induces rapid and persistent growth of dendritic spines in frontal cortex <i>in vivo</i>
    Shao, Ling-Xiao, Liao, Clara, Gregg, Ian, Davoudian, Pasha A., Savalia, Neil K., Delagarza, Kristina, Kwan, Alex C. · 2021
  17. Storm on predictive brain: A neurocomputational account of ketamine antidepressant effect
    Hugo Bottemanne, Lucie Berkovitch, Christophe Gauld, Alexander Balcerac, Liane Schmidt, Stéphane Mouchabac, Philippe Fossati · 2023 · Neuroscience & Biobehavioral Reviews
  18. Sex Differences in the Sustained Effects of Ketamine on Resilience to Chronic Stress
    Tracy Okine, Ryan M. Shepard, Elise A. Lemanski, Laurence D. Coutellier · 2020 · Frontiers in Behavioral Neuroscience
  19. Rapid treatments for depression: Endocannabinoid system as a therapeutic target
    AmirMohammad Sharafi, Sina Pakkhesal, Ali Fakhari, Nazli Khajehnasiri, Ali Ahmadalipour · 2022 · Neuroscience & Biobehavioral Reviews
  20. Pathogenic neuropsychiatric effect of stress-induced microglial interleukin 12/23 axis in systemic lupus erythematosus
    Nobuya Abe, Masato Tarumi, Yuichiro Fujieda, Nobuhiko Takahashi, Kohei Karino, Mona Uchida, Michihito Kono, Yuki Tanaka, Rie Hasebe, Masaru Kato et al. · 2022 · Annals of the Rheumatic Diseases
  21. An integrative view on the cell-type-specific mechanisms of ketamine's antidepressant actions
    Vern Lewis, Gareth M. Rurak, Natalina Salmaso, Argel Aguilar‐Valles · 2024 · Trends in Neurosciences
  22. Mitochondrial Metabolism in Major Depressive Disorder: From Early Diagnosis to Emerging Treatment Options
    Ane Larrea, Laura Sánchez-Sánchez, Eguzkiñe Díez-Martín, Ane Elexpe, Marı́a Torrecilla, Egoitz Astigarraga, Gabriel Barreda‐Gómez · 2024 · Journal of Clinical Medicine
  23. Psilocybin and the glutamatergic pathway: implications for the treatment of neuropsychiatric diseases
    Izabela Szpręgiel, Agnieszka Bysiek · 2024 · Pharmacological Reports
  24. Cumulative Effects of Social Stress on Reward-Guided Actions and Prefrontal Cortical Activity
    Florent Barthas, Melody Y. Hu, Michael J. Siniscalchi, Farhan Ali, Yann S. Mineur, Marina R. Picciotto, Alex C. Kwan · 2019 · Biological Psychiatry
  25. Blocking Astrocytic GABA Restores Synaptic Plasticity in Prefrontal Cortex of Rat Model of Depression
    Ipsit Srivastava, Erika Vázquez‐Juárez, Lukas Henning, Marta Gómez‐Galán, Maria Lindskog · 2020 · Cells
  26. Fluoroethylnormemantine, a Novel NMDA Receptor Antagonist, for the Prevention and Treatment of Stress-Induced Maladaptive Behavior
    Briana K. Chen, Victor M. Luna, Margaret E. Shannon, Holly C. Hunsberger, Alessia Mastrodonato, Michelle Stackmann, Josephine Cecelia McGowan, Gilles Rubinstenn, Christine Ann Denny · 2021 · Biological Psychiatry
  27. Distorted neurocomputation by a small number of extra-large spines in psychiatric disorders
    Kisho Obi-Nagata, Norimitsu Suzuki, Ryuhei Miyake, Matthew L. MacDonald, Kenneth N. Fish, Katsuya Ozawa, Kenichiro Nagahama, Tsukasa Okimura, Shoji Tanaka, Masanobu Kano et al. · 2023 · Science Advances
  28. Novel targets for parkinsonism-depression comorbidity
    Yousef Tizabi, Bruk Getachew, Antonei Benjamin Csoka, Kebreten F. Manaye, Robert Copeland · 2019 · Progress in molecular biology and translational science
  29. Experience and activity-dependent control of glucocorticoid receptors during the stress response in large-scale brain networks
    Damien Huzard, Virginie Rappeneau, Onno Cornelis Meijer, Chadi Touma, Margarita Arango-Lievano, Michael J. Garabedian, Freddy D. Jeanneteau · 2020 · Stress
  30. Primary cilia safeguard cortical neurons in neonatal mouse forebrain from environmental stress-induced dendritic degeneration
    Seiji Ishii, Toru Sasaki, Shahid Mohammad, Hye Mee Hwang, Edwin Tomy, Fahad A. Somaa, Nobuyuki Ishibashi, Hideyuki Okano, PASKO T. RAKIC, Kazue Hashimoto‐Torii et al. · 2020 · Proceedings of the National Academy of Sciences
  31. Structure and function differences in the prelimbic cortex to basolateral amygdala circuit mediate trait vulnerability in a novel model of acute social defeat stress in male mice
    Yael S. Grossman, Clémentine Fillinger, Alessia Manganaro, George Voren, Rachel N. Waldman, Tiffany Zou, William G.M. Janssen, Paul J. Kenny, Dani Dumitriu · 2021 · Neuropsychopharmacology
  32. (R)-ketamine restores anterior insular cortex activity and cognitive deficits in social isolation-reared mice
    Rei Yokoyama, Yukio Ago, Hisato Igarashi, Momoko Higuchi, Masato Tanuma, Yuto Shimazaki, Takafumi Kawai, Kaoru Seiriki, Misuzu Hayashida, Shun Yamaguchi et al. · 2024 · Molecular Psychiatry
  33. Neuregulin signaling mediates the acute and sustained antidepressant effects of subanesthetic ketamine
    Grieco, Steven F., Qiao, Xin, Johnston, Kevin G., Chen, Lujia, Nelson, Renetta R., Lai, Cary, Holmes, Todd C., Xu, Xiangmin · 2021 · Translational Psychiatry
  34. The molecular basis of depression: implications of sex-related differences in epigenetic regulation
    Kawatake-Kuno, Ayako, Murai, Toshiya, Uchida, Shusaku · 2021 · Frontiers in Molecular Neuroscience
  35. A Multiscale View of the Mechanisms Underlying Ketamine’s Antidepressant Effects: An Update on Neuronal Calcium Signaling
    Ayako Kawatake-Kuno, Toshiya Murai, Shusaku Uchida · 2021 · Frontiers in Behavioral Neuroscience
  36. Intranasal (R, S)-ketamine delivery induces sustained antidepressant effects associated with changes in cortical balance of excitatory/inhibitory synaptic activity
    Thi Mai Loan Nguyen, Céline Defaix, Indira Mendez‐David, Laurent Tritschler, Isabelle Etting, Jean‐Claude Alvarez, Walid Choucha, Romain Colle, Emmanuelle Corruble, Denis Joseph Paul David et al. · 2022 · Neuropharmacology
  37. Psilocybin as a lead candidate molecule in preclinical therapeutic studies of psychiatric disorders: A systematic review
    James J Gattuso, Carey Wilson, Anthony John Hannan, Thibault Renoir · 2023 · Journal of Neurochemistry
  38. Ketamine and rapid acting antidepressants: Are we ready to cure, rather than treat depression?
    Chadi G. Abdallah, John Harrison Krystal · 2020 · Behavioural Brain Research
  39. Unraveling the mysteries of dendritic spine dynamics: Five key principles shaping memory and cognition
    Haruo Kasai · 2023 · Proceedings of the Japan Academy Series B
  40. Therapeutic Potential of Psychedelic Drugs: Navigating High Hopes, Strong Claims, Weak Evidence, and Big Money
    Keith N. Humphreys, Philip Todd Korthuis, Daniel Stjepanović, Wayne Hall · 2024 · Annual Review of Psychology
  41. In Situ Recovery of Serotonin Synthesis by a Tryptophan Hydroxylase-Like Nanozyme for the Treatment of Depression
    Xiao Jun Fang, Yuxia Wu, Yaling Dai, Han Xiao, Shiqing Li, Xiaoning Chen, Meng Yuan, Yanbei Guo, Liying Ma, Dingyue Lin et al. · 2025 · Journal of the American Chemical Society
  42. Psilocybin triggers an activity-dependent rewiring of large-scale cortical networks
    Quan Jiang, Ling-Xiao Shao, Shenqin Yao, Neil K. Savalia, Amelia D. Gilbert, Pasha A. Davoudian, Jack D. Nothnagel, Guilian Tian, Jacky Tin Shing Hung, H. M. Lai et al. · 2025 · Cell
  43. Sexually divergent cortical control of affective-autonomic integration
    Tyler Wallace, Derek Schaeuble, Sebastian A. Pace, Morgan K. Schackmuth, Shane T. Hentges, Adam J. Chicco, Brent Myers · 2021 · Psychoneuroendocrinology
  44. Dendritic Spines in Learning and Memory: From First Discoveries to Current Insights
    Nicolas Heck, Marc Dos Santos · 2023 · Advances in neurobiology
  45. Downregulation of Adhesion Molecule CHL1 in B Cells but Not T Cells of Patients with Major Depression and in the Brain of Mice with Chronic Stress
    Chunrui Yang, Li Ning, Fiona H. Zhou, Qinghua Sun, H. P. Meng, Zhenxiang Han, Yuxi Liu, Weibin Huang, S. Liu, X. H. Li et al. · 2020 · Neurotoxicity Research
  46. Environmental certainty influences the neural systems regulating responses to threat and stress
    Heidi C. Meyer, Susan Sangha, Jason J. Radley, Ryan T. LaLumiere, Michael V. Baratta · 2021 · Neuroscience & Biobehavioral Reviews
  47. Repurposing General Anesthetic Drugs to Treat Depression: A New Frontier for Anesthesiologists in Neuropsychiatric Care
    Connor T. A. Brenna, Benjamin I. Goldstein, Carlos A. Zarate, Beverley Anne Orser · 2024 · Anesthesiology
  48. The science of psychedelic medicine
    Joshua S. Siegel, Conor M. Liston, Ginger E. Nicol, Robin Lester Carhart-Harris, Michael P. Bogenschutz · 2026 · Nature Medicine
  49. Disrupting phosphorylation of Tyr-1070 at GluN2B selectively produces resilience to depression-like behaviors
    Xiaofang Shi, Qi Zhang, Jie Li, Xingyu Liu, Yi Zhang, Minhua Huang, Weiqing Fang, Junyu Xu, Tifei Yuan, Lin Xiao et al. · 2021 · Cell Reports
  50. A Novel Assay Allowing Drug Self-Administration, Extinction, and Reinstatement Testing in Head-Restrained Mice
    Kelsey M. Vollmer, Elizabeth M. Doncheck, Roger I. Grant, Kion T. Winston, Elizaveta V Romanova, Christopher W Bowen, Preston N. Siegler, Lisa M. Green, Ana‐Clara Bobadilla, Ivan Trujillo‐Pisanty et al. · 2021 · Frontiers in Behavioral Neuroscience
  51. Brain structure and synaptic protein expression alterations after antidepressant treatment in a Wistar–Kyoto rat model of depression
    Qi Li, Yao Gao, Hong Li, Hongmei Liu, Dan Wang, Weixing X. Pan, Sha Liu, Yong Xu · 2022 · Journal of Affective Disorders
  52. Where do we go next in antidepressant drug discovery? A new generation of antidepressants: a pivotal role of AMPA receptor potentiation and mGlu2/3 receptor antagonism
    Andrzej Pilc, Agata Machaczka, Paweł Kawalec, Jodi L. Smith, Jeffrey M. Witkin · 2022 · Expert Opinion on Drug Discovery
  53. Lasting dynamic effects of the psychedelic 2,5-dimethoxy-4-iodoamphetamine ((±)-DOI) on cognitive flexibility
    Merima Šabanović, Alberto Lazari, Marta Blanco-Pozo, Cristiana Tisca, Mohamed Tachrount, Aurea B. Martins-Bach, Jason P. Lerch, Mark E. Walton, David M. Bannerman · 2024 · Molecular Psychiatry
  54. Chronic Stress Induces Coordinated Cortical Microcircuit Cell–Type Transcriptomic Changes Consistent With Altered Information Processing
    Newton, Dwight F., Oh, Hyunjung, Shukla, Rammohan, Misquitta, Keith, Fee, Corey, Banasr, Mounira, Sibille, Etienne · 2022 · Biological Psychiatry
  55. Dysfunction in primate dorsolateral prefrontal area 46 affects motivation and anxiety
    Christian M. Wood, Rana Banai Tizkar, Martina Fort, Xinhu Zhang, Kevin G. Mulvihill, Naixuan Liao, Gemma J. Cockcroft, Lauren B. McIver, Stephen J. Sawiak, Angela Roberts · 2025 · Science
  56. Decreased Plasma Hydrogen Sulfide Level Is Associated With the Severity of Depression in Patients With Depressive Disorder
    Yuan‐Jian Yang, Chunnuan Chen, Jin‐Qiong Zhan, Qiao-Sheng Liu, Yun Liu, Shu-Zhen Jiang, Bo Wei · 2021 · Frontiers in Psychiatry
  57. Neurogenesis mediated plasticity is associated with reduced neuronal activity in CA1 during context fear memory retrieval
    Alexandria Evans, Dylan J. Terstege, Gavin A. Scott, Mio Tsutsui, Jonathan R. Epp · 2022 · Scientific Reports
  58. Psychedelics: preclinical insights provide directions for future research
    Ryan H. Gumpper, Bryan L. Roth · 2023 · Neuropsychopharmacology
  59. In situ fluorescence imaging reveals that mitochondrial H 2 O 2 mediates lysosomal dysfunction in depression
    Xin Wang, Qi Ding, Ying Tian, Wei Wu, Feida Che, Ping Li, Wen Zhang, Wei Zhang, Bo Tang · 2022 · Chemical Communications
  60. Translational control by ketamine and its implications for comorbid cognitive deficits in depressive disorders
    Vern Lewis, Brandon Rodrigue, Emily Arsenault, Molly Zhang, Fatimeh‐Frouh Taghavi‐Abkuh, Weverton Castro Coelho Silva, Mysa Myers, Edna Matta‐Camacho, Argel Aguilar‐Valles · 2022 · Journal of Neurochemistry
  61. Optogenetic Control of Spine-Head JNK Reveals a Role in Dendritic Spine Regression
    Patrik Hollós, Jismi John, Jukka V. Lehtonen, Eleanor T. Coffey · 2020 · eNeuro
  62. The Downstaging Concept in Treatment-Resistant Depression: Spotlight on Ketamine
    Alina Wilkowska, Wiesław Jerzy Cubała · 2022 · International Journal of Molecular Sciences
  63. Psychedelics and the ‘inner healer’: Myth or mechanism?
    Joseph M. Peill, M. Marguilho, David Erritzøe, Tommaso Barba, Kyle T. Greenway, Fernando E. Rosas, Christopher Timmermann, Robin Lester Carhart-Harris · 2024 · Journal of Psychopharmacology
  64. Beyond NMDA Receptors: A Narrative Review of Ketamine’s Rapid and Multifaceted Mechanisms in Depression Treatment
    Antos, Zuzanna, Żukow, Xawery, Bursztynowicz, Laura, Jakubów, Piotr · 2024 · International Journal of Molecular Sciences
  65. The 2019 yearbook of Neurorestoratology
    Hong-Yun Huang, Lin Chen, Gengsheng Mao, J. Bach, Q. Xue, F. Han, Xiao-Ling Guo, A. Otom, E. Chernykh, Edgardo O. Alvarez et al. · 2020 · Journal of Neurorestoratology
  66. Prolonged anesthesia alters brain synaptic architecture
    Michael Wenzel, Alexander Leunig, Shuting Han, Darcy S. Peterka, Rafael Yuste · 2021 · Proceedings of the National Academy of Sciences
  67. Rapid‐acting antidepressants and the regulation of TrkB neurotrophic signalling—Insights from ketamine, nitrous oxide, seizures and anaesthesia
    Samuel Kohtala, Tomi Rantamäki · 2021 · Basic & Clinical Pharmacology & Toxicology
  68. Assessment of Objective and Subjective Cognitive Function in Patients With Treatment-Resistant Depression Undergoing Repeated Ketamine Infusions
    Jennifer Lynne Phillips, Amanda Van Geel, Patricia Burhunduli, Dominique Vasudev, Lisa A. Batten, Sandhaya Norris, Jeanne D. Talbot, Abigail Ortiz, Olabisi Owoeye, Pierre Blier · 2022 · The International Journal of Neuropsychopharmacology
  69. Weapons of stress reduction: (R,S)-ketamine and its metabolites as prophylactics for the prevention of stress-induced psychiatric disorders
    Briana K. Chen, Christine Ann Denny · 2022 · Neuropharmacology
  70. Calcium transients in nNOS neurons underlie distinct phases of the neurovascular response to barrel cortex activation in awake mice
    Sung Ji Ahn, Antoine Anfray, Josef Anrather, Costantino Iadecola · 2023 · Journal of Cerebral Blood Flow & Metabolism
  71. Early-life stress contributes to depression-like behaviors in a two-hit mouse model
    Shilong Deng, Ruxin Xie, Anqi Kong, Yi Luo, Jianghui Li, Mei Chen, Xiaqing Wang, Hong Gong, Lian Wang, Xiaotang Fan et al. · 2023 · Behavioural Brain Research
  72. The PrLGlu→avBNSTGABA circuit rapidly modulates depression-like behaviors in male mice
    Jie-ying Chen, Ke Wu, Miaomiao Guo, Wei Song, Si-Ting Huang, Yong-Mei Zhang · 2023 · iScience
  73. Activity in the dorsal hippocampus-mPFC circuit modulates stress-coping strategies during inescapable stress
    Sang Ho Yoon, Woo Seok Song, Geehoon Chung, Sang Jeong Kim, Myoung‐Hwan Kim · 2024 · Experimental & Molecular Medicine
  74. Effects of ketamine on orientation selectivity and variability of neuronal responses in primary visual cortex
    Afef Ouelhazi, Vishal Bharmauria, Nayan Chanauria, Lyes Bachatene, Rudy Lussiez, St�phane Molotchnikoff · 2019 · Brain Research
  75. Dynorphin/Kappa-Opioid Receptor System Modulation of Cortical Circuitry
    Hugo A. Tejeda, Huikun Wang, Rodolfo J. Flores, Héctor E. Yarur · 2021 · Handbook of experimental pharmacology
  76. A wake-up call: Sleep physiology and related translational discrepancies in studies of rapid-acting antidepressants
    Okko Alitalo, Roosa Saarreharju, Ioline D. Henter, Carlos A. Zarate, Samuel Kohtala, Tomi Rantamäki · 2021 · Progress in Neurobiology
  77. The role of NMDARs in the anesthetic and antidepressant effects of ketamine
    Liang Zhou, Jingjing Duan · 2023 · CNS Neuroscience & Therapeutics
  78. Whole-brain mapping reveals the divergent impact of ketamine on the dopamine system
    Malika S. Datta, Yannan Chen, Shradha Chauhan, Jing Zhang, Estanislao Daniel De La Cruz, Cheng Gong, Raju Tomer · 2023 · Cell Reports
  79. Social experience in adolescence shapes prefrontal cortex structure and function in adulthood
    Dan C. Li, Elizabeth A. Hinton, Jidong Guo, Kristopher A. Knight, Michelle K. Sequeira, Meghan E. Wynne, Niharika M. Dighe, Shannon L. Gourley · 2024 · Molecular Psychiatry
  80. Shared effects of electroconvulsive shocks and ketamine on neuroplasticity: A systematic review of animal models of depression
    Jesca E. De Jager, Rutger Boesjes, Gijs H. J. Roelandt, Ilektra Koliaki, Iris E. Sommer, Robert A. Schoevers, Jasper O. Nuninga · 2024 · Neuroscience & Biobehavioral Reviews
  81. NMDAR Neurotransmission Needed for Persistent Neuronal Firing: Potential Roles in Mental Disorders
    Shengtao Yang, Hyojung Seo, Min Wang, Amy F.T. Arnsten · 2021 · Frontiers in Psychiatry
  82. Loss of glucocorticoid receptor phosphorylation contributes to cognitive and neurocentric damages of the amyloid-β pathway
    Yann Dromard, Margarita Arango-Lievano, Amélie M. Borie, Maheva Dedin, Pierre Fontanaud, Joan Torrent, Michael J. Garabedian, Stephen D. Ginsberg, Freddy D. Jeanneteau · 2022 · Acta Neuropathologica Communications
  83. The stressed orbitofrontal cortex.
    Michelle K. Sequeira, Shannon L. Gourley · 2021 · Behavioral Neuroscience
  84. Neurochemical mechanisms of deep brain stimulation for depression in animal models
    Ana Carolina Pinheiro Campos, Christopher B. Pople, Esther Silk, Shanan Surendrakumar, Thallita Kelly Rabelo, Ying Meng, Flavia Venetucci Gouveia, Nir Lipsman, Peter Giacobbe, Clement Hamani · 2023 · European Neuropsychopharmacology
  85. Shaping Memories via Stress: A Synaptic Engram Perspective
    Niek Brosens, Sylvie L. Lesuis, Priyanka Rao‐Ruiz, Michel C. van den Oever, Harm J. Krugers · 2023 · Biological Psychiatry
  86. Three-photon in vivo imaging of neurons and glia in the medial prefrontal cortex with sub-cellular resolution
    Falko Fuhrmann, Felix Christopher Nebeling, Fabrizio Musacchio, Manuel Mittag, Stefanie Poll, Monika C. M. Müller, Eleonora Ambrad Giovannetti, Michael Maibach, Barbara Schaffran, Emily R. Burnside et al. · 2025 · Communications Biology
  87. Ketamine: Leading us into the future for development of antidepressants
    Flavia Regina Carreno, Daniel J. Lodge, Alan Frazer · 2020 · Behavioural Brain Research
  88. Chronic Stress Oppositely Regulates Tonic Inhibition in Thy1-Expressing and Non-expressing Neurons in Amygdala
    Han‐Qing Pan, Wenhua Zhang, Cai-Zhi Liao, Ye He, Zhi-Ming Xiao, Xia Qin, Wei-Zhu Liu, Na Wang, Jiaxin Zou, Xiaoxuan Liu et al. · 2020 · Frontiers in Neuroscience
  89. Antidepressant Response and Stress Resilience Are Promoted by CART Peptides in GABAergic Neurons of the Anterior Cingulate Cortex
    Yuki Funayama, Haiyan Li, Erina Ishimori, Ayako Kawatake-Kuno, Hiromichi Inaba, Hirotaka Yamagata, Tomoe Seki, Shin Nakagawa, Yoshifumi Watanabe, Toshiya Murai et al. · 2022 · Biological Psychiatry Global Open Science
  90. Connectivity of the Cerebello-Thalamo-Cortical Pathway in Survivors of Childhood Leukemia Treated With Chemotherapy Only
    Nicholas Steve Phillips, Shelli R. Kesler, Matthew Scoggins, John O. Glass, Yin Ting Cheung, Wei Liu, Pia Banerjee, Robert J. Ogg, Deo Kumar Srivastava, Ching‐Hon Pui et al. · 2020 · JAMA Network Open
  91. Ketamine treatment upon memory retrieval reduces fear memory in marmoset monkeys
    Ingrid H.C.H.M. Philippens, Laurijn R. Draaisma, Guus Baarends, Harm J. Krugers, Eric H. G. J. M. Vermetten · 2021 · European Neuropsychopharmacology
  92. Lycopene Alleviates Depression‐Like Behavior in Chronic Social Defeat Stress‐Induced Mice by Promoting Synaptic Plasticity via the BDNF – T rk B Pathway
    Heyan Xu, Yuna Wang, Dandan Geng, Fengming Chen, Yujia Chen, Lisa Cynthia Niwenahisemo, Lei Shi, Ning Du, Ziqiang He, Xiaoming Xu et al. · 2025 · Food Science & Nutrition
  93. Microglial BDNF modulates arketamine’s antidepressant-like effects through cortico-accumbal pathways
    Lujuan He, Xuenan Wang, Shilin Luo, Nan Jiang, Yu Yan, Min Xie, Yueyue Chen, Chun Yang, Wei Yao, Kenji Hashimoto et al. · 2025 · Science Advances
  94. The role of astrocytes in behaviors related to emotion and motivation
    Eiji Shigetomi, Schuichi Koizumi · 2022 · Neuroscience Research
  95. A Multifunctional Nanocarrier System for Highly Efficient and Targeted Delivery of Ketamine to NMDAR Sites for Improved Treatment of Depression
    Jing Ge, Ronghua Tan, Qian Gao, Rui Li, Peng‐xin Xu, Hang Song, Shenqi Wang, Ying Wan, Lei Zhou · 2023 · Advanced Healthcare Materials
  96. Changes in synaptic markers after administration of ketamine or psychedelics: a systematic scoping review
    Simon Zhornitsky, Henrique Nunes Pereira Oliva, Laura A. Jayne, AZA Stephen Allsop, Alfred P. Kaye, Marc Nicholas Potenza, Gustavo A. Angarita · 2023 · Frontiers in Psychiatry
  97. Serum levels of D-cycloserine predict antidepressant effects in pharmacologically enhanced intermittent theta-burst stimulation
    Marilena M. DeMayo, Molly Watson, Ashley D. Harris, Alexander McGirr · 2025 · Journal of Affective Disorders
  98. Not So Fast
    Bashkim Kadriu, Zhi‐De Deng, Christoph Kraus, Ioline D. Henter, Sarah Hollingsworth Lisanby, Carlos A. Zarate · 2020 · The Journal of Clinical Psychiatry
  99. “Novel Psychopharmacology for Depressive Disorders”
    Michele Fornaro, Domenico De Berardis, Annalisa Anastasia, Andrea Fusco · 2021 · Advances in experimental medicine and biology
  100. Stress, mental disorder and ketamine as a novel, rapid acting treatment
    Megan Dutton, Adem Can, Jim Lagopoulos, Daniel Francis Hermens · 2022 · European Neuropsychopharmacology